BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 25159915)

  • 1. Diverse modes of genomic alteration in hepatocellular carcinoma.
    Jhunjhunwala S; Jiang Z; Stawiski EW; Gnad F; Liu J; Mayba O; Du P; Diao J; Johnson S; Wong KF; Gao Z; Li Y; Wu TD; Kapadia SB; Modrusan Z; French DM; Luk JM; Seshagiri S; Zhang Z
    Genome Biol; 2014 Aug; 15(8):436. PubMed ID: 25159915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
    Kawai-Kitahata F; Asahina Y; Tanaka S; Kakinuma S; Murakawa M; Nitta S; Watanabe T; Otani S; Taniguchi M; Goto F; Nagata H; Kaneko S; Tasaka-Fujita M; Nishimura-Sakurai Y; Azuma S; Itsui Y; Nakagawa M; Tanabe M; Takano S; Fukasawa M; Sakamoto M; Maekawa S; Enomoto N; Watanabe M
    J Gastroenterol; 2016 May; 51(5):473-86. PubMed ID: 26553052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas.
    Amaddeo G; Cao Q; Ladeiro Y; Imbeaud S; Nault JC; Jaoui D; Gaston Mathe Y; Laurent C; Laurent A; Bioulac-Sage P; Calderaro J; Zucman-Rossi J
    Gut; 2015 May; 64(5):820-9. PubMed ID: 25021421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
    Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
    Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma.
    Gu DL; Chen YH; Shih JH; Lin CH; Jou YS; Chen CF
    World J Gastroenterol; 2013 Dec; 19(47):8873-9. PubMed ID: 24379610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma.
    Xue R; Li R; Guo H; Guo L; Su Z; Ni X; Qi L; Zhang T; Li Q; Zhang Z; Xie XS; Bai F; Zhang N
    Gastroenterology; 2016 Apr; 150(4):998-1008. PubMed ID: 26752112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.
    Joseph NM; Tsokos CG; Umetsu SE; Shain AH; Kelley RK; Onodera C; Bowman S; Talevich E; Ferrell LD; Kakar S; Krings G
    J Pathol; 2019 Jun; 248(2):164-178. PubMed ID: 30690729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection.
    Saitta C; Lanza M; Bertuccio A; Lazzara S; Navarra G; Raimondo G; Pollicino T
    Cancer Genet; 2015 Oct; 208(10):513-6. PubMed ID: 26341700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations.
    Toh ST; Jin Y; Liu L; Wang J; Babrzadeh F; Gharizadeh B; Ronaghi M; Toh HC; Chow PK; Chung AY; Ooi LL; Lee CG
    Carcinogenesis; 2013 Apr; 34(4):787-98. PubMed ID: 23276797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Patterns of HBV Integration and
    Jang JW; Kim HS; Kim JS; Lee SK; Han JW; Sung PS; Bae SH; Choi JY; Yoon SK; Han DJ; Kim TM; Roberts LR
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NGS-based profiling reveals a critical contributing role of somatic D-loop mtDNA mutations in HBV-related hepatocarcinogenesis.
    Yin C; Li DY; Guo X; Cao HY; Chen YB; Zhou F; Ge NJ; Liu Y; Guo SS; Zhao Z; Yang HS; Xing JL
    Ann Oncol; 2019 Jun; 30(6):953-962. PubMed ID: 30887045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
    Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
    Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma.
    Jin Y; Lee WY; Toh ST; Tennakoon C; Toh HC; Chow PK; Chung AY; Chong SS; Ooi LL; Sung WK; Lee CG
    J Transl Med; 2019 Aug; 17(1):273. PubMed ID: 31429776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis.
    Yoo S; Wang W; Wang Q; Fiel MI; Lee E; Hiotis SP; Zhu J
    BMC Med; 2017 Dec; 15(1):214. PubMed ID: 29212479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
    Li S; Mao M
    Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma.
    Sze KM; Ho DW; Chiu YT; Tsui YM; Chan LK; Lee JM; Chok KS; Chan AC; Tang CN; Tang VW; Lo IL; Yau DT; Cheung TT; Ng IO
    Hepatology; 2021 Jan; 73(1):23-40. PubMed ID: 32170761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region.
    Li CL; Li CY; Lin YY; Ho MC; Chen DS; Chen PJ; Yeh SH
    Hepatology; 2019 Feb; 69(2):498-512. PubMed ID: 30070724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic landscape of hepatocarcinogenesis.
    Shibata T
    J Hum Genet; 2021 Sep; 66(9):845-851. PubMed ID: 33958712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.